Gene · 3239
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Porous Polymer Films with Tunable Pore Size and Morphology by Vapor Deposition. | ACS Appl Polym Mater | 2022 | 36277175 | PubTator, text mining | PubMed |
| Efficacy evaluation of multi-immunotherapy in ovarian cancer: From bench to bed. | Front Immunol | 2022 | 36275669 | PubTator, text mining | PubMed |
| Hotspot mutations in the structured ENL YEATS domain link aberrant transcriptional condensates and cancer. | Mol Cell | 2022 | 36272410 | PubTator, text mining | PubMed |
| Lenvatinib plus transarterial chemoembolization with or without immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A review. | Front Oncol | 2022 | 36249023 | PubTator, text mining | PubMed |
| Who polarizes Twitter? Ideological polarization, partisan groups and strategic networked campaigning on Twitter during the 2017 and 2021 German Federal elections 'Bundestagswahlen'. | Soc Netw Anal Min | 2022 | 36246430 | PubTator, text mining | PubMed |
| Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes. | Comput Math Methods Med | 2022 | 36213580 | PubTator, text mining | PubMed |
| Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? | Front Oncol | 2022 | 36212445 | PubTator, text mining | PubMed |
| Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19. | Front Immunol | 2022 | 36211412 | PubTator, text mining | PubMed |
| Multi-location evaluation of mungbean (Vigna radiata L.) in Indian climates: Ecophenological dynamics, yield relation, and characterization of locations. | Front Plant Sci | 2022 | 36204050 | PubTator, text mining | PubMed |
| Identification of a HOXD13 variant in a Mongolian family with incomplete penetrance syndactyly by exon sequencing. | BMC Med Genomics | 2022 | 36195906 | PubTator, text mining | PubMed |
| HOX genes in stem cells: Maintaining cellular identity and regulation of differentiation. | Front Cell Dev Biol | 2022 | 36176275 | PubTator, text mining | PubMed |
| Delivery of ceramide phosphoethanolamine lipids to the cleavage furrow through the endocytic pathway is essential for male meiotic cytokinesis. | PLoS Biol | 2022 | 36170207 | PubTator, text mining | PubMed |
| TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma. | Mol Cancer | 2022 | 36163179 | PubTator, text mining | PubMed |
| New dual dye for vitreoretinal surgery with increased transparency. | BMJ Open Ophthalmol | 2022 | 36161825 | PubTator, text mining | PubMed |
| Transcriptome Sequencing Analysis of the Effect of β-Elemene on Colorectal Cancer from the lncRNA-miRNA-mRNA Perspective. | Genet Res (Camb) | 2022 | 36160034 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor. | Cell Rep | 2022 | 36130486 | PubTator, text mining | PubMed |
| EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma. | Nucleic Acids Res | 2022 | 36124657 | PubTator, text mining | PubMed |
| Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer. | Front Immunol | 2022 | 36119046 | PubTator, text mining | PubMed |
| Higher serum sPD-L1 levels after radiotherapy indicate poor outcome in hepatocellular carcinoma patients. | Transl Oncol | 2022 | 36115075 | PubTator, text mining | PubMed |
| The in vivo Interaction Landscape of Histones H3.1 and H3.3. | Mol Cell Proteomics | 2022 | 36089195 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3239/papers?page=20